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In schistosomiasis, egg-induced hepatic granuloma formation is a cytokine-mediated, predominantly CD4þ
Th2 immune response that can give rise to hepatic ﬁbrosis. Hepatic ﬁbrosis is the main cause of increased
morbidity andmortality in humans with schistosome infection. Taurine has various physiological functions
and hepatoprotective properties as well as anti-inﬂammatory and immunomodulatory activity. However,
little is known about the role of taurine in schistosome egg-induced granuloma formation and ﬁbrosis. We
aimed to evaluate the therapeutic potential of taurine as preventative treatment for Schistosoma japonicum
infection.Mice infectedwith S. japonicum cercariaewere suppliedwith taurine drinkingwater (1%w/v) for 4
weeks starting at 4 weeks post-infection. Taurine supplementation signiﬁcantly improved the liver path-
ologic ﬁndings, reduced the serum levels of aminotransferases and area of hepatic granuloma, and pre-
vented ﬁbrosis progression. In addition, taurine decreased the expression of the granulomatous and
ﬁbrogenic mediators transforming growth factor b1, tumor necrosis factor a, monocyte chemotactic protein
1a and macrophage inﬂammatory protein 1a as well as the endoplasmic reticulum stress marker glucose-
regulated protein 78. Thus, taurine can signiﬁcantly attenuate S. japonicum egg-induced hepatic granuloma
and ﬁbrosis, which may depend in part on the downregulation of some relevant cytokine/chemokines and
reducing the endoplasmic reticulum stress response.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Schistosomiasis is one of the most widely occurring neglected
tropical diseases, with high incidence in Asia, Africa and Latin
America. About 207 million people have been infected worldwide
and 780 million people are at risk of infection, and more than 240
million patients require treatment each year (Beckmann et al.,
2014; Guimar~aes et al., 2015). Schistosoma japonicum
(S. japonicum) is the major causative agent in Southeast Asia and
China. The presence of eggs from S. japonicum in the host liver and
intestinal tissue is the major cause of pathologic schistosomiasis.
During infection, schistosome eggs are trapped in the host liver and
stimulate the granulomatous response. Subsequent signiﬁcantology, School of Basic Medical
ijing 100191, China.
ology, School of Basic Medical
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dividuals with extensive or repeated infection and/or lack of
treatment (Liu et al., 2013). Hepatic ﬁbrosis is the principal cause of
morbidity and mortality in humans with schistosome infection.
However, effective medical interventions to control and treat
granuloma and ﬁbrosis in schistosomiasis are lacking.
Granulomatous reaction of schistosome is the CD4þ T cell-
mediated delayed-type hypersensitivity induced by soluble egg
antigen secreted from viable miracidium within eggs trapped in
host tissues. The formation of granulomas is a dynamic process that
involves the accumulation of inﬂammatory and immune cells at the
site of antigen release, leading to the conﬁnement of the eliciting
agent (Chuah et al., 2014). Toward the late stage, ﬁbroblasts are
stimulated by egg products and by T-lymphocyte cytokines to
proliferate, replacing most of the cellular elements and mediating
ﬁbrotic collagenous material deposition around the portal vein
tributaries (Olveda et al., 2014). Many factors are involved in
regulating the immunopathogenesis of schistosomiasis. T helper
1 cell (Th1) and Th2 cytokines determine the hepatic granuloma
size (Liu et al., 2013; Chuah et al., 2014), and Th17 responses haveor Parasitology. This is an open access article under the CC BY-NC-ND license (http://
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(Chuah et al., 2014). Chemokines, particularly macrophage in-
ﬂammatory protein 1a (MIP-1a) andmonocyte chemotactic protein
1a (MCP-1a), play major roles in the formation of hepatic granu-
loma. Mice deﬁcient in MIP-1a show decreased hepatic granuloma
size and both ﬁbrosis and eosinophil peroxidase activity (Souza
et al., 2005). MCP-1a, can be produced by activated hepatic stel-
late cells (HSCs) following liver injury, showed increased tran-
scriptional levels during S. japonicum infection correlates with peak
ﬁbrosis (Bartley et al., 2006). Transforming growth factor-b1 (TGF-
b1) is the most potent ﬁbrogenic cytokine in the liver. TGF-b1 ac-
tivates and transforms HSCs into myoﬁbroblast-like cells, which
express a-smooth muscle actin (a-SMA) and secrete collagens
containing hydrohyproline that form extracellular matrix (ECM)
ﬁbrosis (Dooley and ten Dijke, 2012; Sun et al., 2015). In addition,
pro-inﬂammatory stimulation, oxidative stress and tissue damage
may play important roles in schistosomiasis (Cunha et al., 2012; de
Oliveira et al., 2013).
Taurine (2-aminoethane sulfonic acid), a sulfur-containing b-
amino acid, is ubiquitously distributed in animal tissues and cells,
accounts for approximately 0.1% of total human body weight. It is
both synthesized endogenously from cysteine and methionine and
ingested directly with certain foodstuffs. According to the European
Food Safety Authority, taurine (3e6 g) has been administered daily
to a large number of patients (including adults, children and even
infants). No adverse health effects have been noted (Schaffer et al.,
2014). In recent years taurine has been widely used as a
performance-enhancing ingredient in energy drinks (Luckose et al.,
2015). In general, oral taurine can be absorbed by gastrointestinal
tract, plasma proteins combination with taurine are fewer. Taurine
dischargesmainly in prototype and kidney can adjust the content of
taurine in the body. The normal concentration of taurine in the
plasma is very low (e.g.<60 mM in cat) but most tissues contain very
high taurine levels (mM range), creating a substantial concentra-
tion gradient across the cell membrane (Schaffer et al., 2014). The
half-life of turnover of taurine in the mouse was 18.6 days
(Huxtable and Lippincott, 1982). Taurine has various physiological
functions and protective properties including protection against
various types of hepatic damage (Gentile et al., 2011). In addition,
taurine possesses anti-inﬂammatory and immunoregulatory
properties (De Luca et al., 2015). Previous studies have demon-
strated that exogenous supplementation with taurine can prevent
liver injury caused by different harmful substances as well as
inhibit ECM deposition on the damaged liver and stop the process
of liver ﬁbrosis (Miyazaki et al., 2005; Devi et al., 2009, 2010;
Gentile et al., 2011). Mice with hetero- and homozygous knockout
of the taurine transporter show chronic liver disease characterized
by ﬁbrosis, inﬂammation, and hepatocyte apoptosis (Warskulat
et al., 2006). The hepatoprotective effects of taurine are often
accompanied by reduced endoplasmic reticulum (ER) stress,
oxidative stress, production of inﬂammatory and ﬁbrogenic medi-
ators and activation of stellate cells (Erman et al., 2004; Devi et al.,
2010; Gentile et al., 2011). However, whether taurine supplemen-
tation can affect the pathological processes of hepatic granulomas
and ﬁbrosis elicited by S. japonicum infection is not known.
In this paper, we aimed to determine the effect of taurine sup-
plementation on granuloma formation and the ﬁbrosis process in
an animal model of S. japonicum infection to assess its potential as
preventative and therapeutic treatment for schistosomiasis.
Miyazaki et al. (2004) reported that the effective and optimal doses
of oral taurine administration for twoweeks on a transient exercise
performance in rat were between 100 and 500 mg/kg/day. Various
reports have described the experimental use of taurine supple-
mented in drinking water in mice over the concentration range of
0.05%~5% (Ribeiro et al., 2010; Santora et al., 2013; Santos-Silvaet al., 2015). Hence, we used 1% taurine supplementation in our
experiment. We found that taurine supplementation could sup-
press S. japonicum egg-induced liver granuloma and ﬁbrosis in
mice.
2. Materials and methods
2.1. Parasite and animals
S. japonicum (Chinese mainland strain)-infected Oncomelania
hupensis snails were purchased from the Jiangsu Institute of Para-
sitic Diseases (Wuxi, Jiangsu, China). Female ICR mice, 6e8 weeks
old, were from the Department of Laboratory Animal Science of
Peking University Health Science Center (Beijing). All animal care
and experimental protocols complied with the Guide for the Care
and Use of Laboratory Animals published by the US National In-
stitutes of Health (NIH Publication, 8th Edition, 2011) and were
approved by the Animal Care Committee of Peking University
Health Science Center.
2.2. Infection of mice with S. japonicum
S. japonicum cercariae were shed in a beaker after exposing
infected Oncomelania to light for 6 h in 24e28 C. The mice were
infected percutaneously with 30 ± 2 freshly shed cercariae after
they had been anesthetized by intraperitoneal injection of
ketamine.
2.3. Experimental group and taurine treatment
Mice were randomly divided into three groups for treatment (10
mice per group): 1) control (Con), mice not infected with
S. japonicum and fed standard chow; 2) infected (Inf), mice infected
with S. japonicum and fed standard chow; 3) infected/taurine (Tau),
mice infected with S. japonicum, fed standard chow and 1% taurine
(Sigma, MO, USA) in drinking water for 4 weeks starting at 4 weeks
post-infection. At 8 weeks post-infection, the body weight of each
mouse was weighed and serum was separated from blood taken
from the mouse eye socket, then mice were killed by cervical
dislocation, and liver tissue and serum samples were collected for
analysis.
2.4. Liver and spleen indexes, egg burden
The liver and spleen tissue was weighed. Liver and spleen in-
dexes were calculated as ratios of liver to bodyweight and spleen to
body weight, respectively.
To determine the egg burden, 1 g of each liver was digested with
5% KOH at 37 C overnight. After centrifugation, released eggs in the
liver were then determined by microscopic examination.
2.5. Analysis of liver transaminase activity
Liver injury was assessed by measuring serum levels of alanine
aminotransferase (ALT) and aspartate aminotransferase (AST) by
use of an Olympus AU5800 automatic biochemical analyzer
(Olympus, Japan).
2.6. Histology and immunohistochemistry (IHC) of liver sections
Excised livers were instantly ﬁxed in 10% neutral formalin
overnight and embedded in parafﬁn. For histology, according to
standard procedures, tissue sections (4 mm) were stained with
hematoxylin and eosin (H&E) to examine the area of the granu-
lomas or with Masson trichrome to evaluate the extent of hepatic
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Leica DMI 3000B ﬂuorescencemicroscope. The granulomatous area
as a percentage of total area for each side was measured by
computer-assisted morphometric software (Leica Application Suite
4.1). For each specimen, at least three non-contiguous slides were
measured and the mean values from 6 to 8 mice for each group
were used for statistical analysis.
Tissue underwent immunostaining for anti-a-SMA antibody, a
marker of HSC activation, and glucose-regulated protein 78
(GRP78), an ER stress marker (Abcam, Cambridge, UK). Six to 10
microphotographs per mouse liver were recorded under an inver-
ted microscope (Leica DMI 3000B). At least three non-contiguous
tissue sections were measured, and the mean values from 6 to 8
mice were used for statistical analysis.
2.7. Quantitative PCR
Total RNA was extracted from liver tissue of each mouse by use
of Trizol Reagent (Applygen Technologies, Beijing). In total, 1 mg
RNA was reverse-transcribed to cDNA by use of the PrimeScript RT
reagent kit (TaKaRa Biotechnology, Dalian, China). Real-time PCR
experiments were performed in triplicate with SYBR premix Ex
TaqTM Ⅱ (TaKaRa Biotechnology) on an ABI 7500 Fast Real-Time PCR
System (Applied Biosystems, Fullerton, CA). The PCR primers were
designed by use of the Primer-BLAST tool on the NCBI website; data
on primers are in Table 1. Levels of target genes were normalized to
that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a
housekeeping gene (Jakubowski et al., 2005; Tang et al., 2014).
Relative mRNA expression was analyzed by use of Applied Bio-
systems 7500 Software and calculated by the comparative Ct
method with the formula 2△△Ct.
2.8. Statistical analysis
Results were presented as mean ± SEM. Statistical analysis
involved use of GraphPad Prism 5 for Windows (GraphPas Soft-
ware, San Diego, CA, USA). One-way and two-way ANOVAwas used
to for analysis. P < 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Taurine treatment improves the gross appearance and
decreases liver and spleen indexes of S. japonicum-infected mice
After infection of S. japonicum, infected mice showed typical
manifestations, including diarrhea and athrepsia. The survival rates
of infected and infected/taurine-treated groups were 60% and 80%,Table 1
Gene-speciﬁc primers used for quantitative real-time RT-PCR.



















F: forward; R: reverse; TNF-a: tumor necrosis factor-alpha; TGF-b1: transforming gro
monocyte chemotactic protein 1 alpha; GRP78: 78 kDa glucose-regulated protein; GAPDrespectively, at 8 weeks post-infection, and hence, subsequent data
collection involved less than the 10 mice initially allocated to each
treatment group.
To evaluate the general effect of taurine on the pathologic fea-
tures of S. japonicum-infected mice, control, infected and infected/
taurine-treated mice were weighed and killed, the gross appear-
ance of liver and spleenwas observed, and liver and spleen indexes
were measured. Normal livers were light red with a smooth surface
after blood removal, whereas infected livers were darker red, with
many small white spots on the surface, indicating many granuloma
nodules. Livers from taurine-treated mice showed an improved
appearance over infection alone and fewer white spots (Fig. 1A).
The size of spleen increased greatly at 8 weeks post-infection, and
taurine treatment attenuated this increase (Fig. 1A). In addition,
body weight was lower in infected than control mice but was
slightly higher with taurine treatment than with infection alone
(data not shown). Liver and spleen indexes were higher for infected
than control mice (all p < 0.01) (Fig. 1B). Accordingly, taurine
treatment attenuated this increase (p < 0.05 and p < 0.01, respec-
tively). Therefore, taurine treatment improved the gross appear-
ance of livers and decreased liver and spleen indexes of
S. japonicum-infected mice.3.2. Taurine treatment attenuates hepatic injury of S. japonicum-
infected mice
We further evaluated the effect of taurine on the hepatic injury
of S. japonicum-infected mice. The serum ALT and AST levels were
higher in infected than control mice (p < 0.05 and p < 0.01,
respectively) and were lower with taurine treatment than with
infection alone (Fig. 2, all p < 0.05). Hence, taurine treatment may
attenuate the hepatic injury of S. japonicum-infected mice.3.3. Egg burden is similar in taurine treated and untreated mice
infected with S. japonicum
The soluble egg antigen secreted by matured schistosome
miracidium within eggs is believed to cause a granulomatous
response, so egg load in liver determines the severity of liver pa-
thology.We evaluated the egg burden of liver in taurine treated and
untreated mice infected with S. japonicum. Result showed similar
liver egg burden between taurine treated and untreated mice
(Fig. 3). This result implies that taurine treatment can not affect the
deposition of eggs on the liver and the ameliorative effect of taurine







wth factor-beta 1; MIP-1a: macrophage inﬂammatory protein 1 alpha; MCP-1a:
H: glyceraldehyde-3-phosphate dehydrogenase.
Fig. 1. Taurine improves the gross appearance and decreases liver and spleen indexes of Schistosoma japonicum-infected mice. ICR mice were infected percutaneously with 30 ± 2 S.
japonicum cercaria. S. japonicum-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. (A) Gross appearance of the liver and spleen of
control, infected and infected/taurine-treated mice. (B) Liver and spleen indexes. Data are mean ± SEM of 6e10 mice/group. Con: control group; Inf: infected group; Tau: infected/
taurine-treated group. *p < 0.05, **p < 0.01 vs Con; &: p < 0.05, &&: p < 0.01 vs Inf.
Fig. 2. Effect of taurine on the levels of serum transaminases (ALT/AST) of S. japoni-
cum-infected mice. ICR mice were infected percutaneously with 30 ± 2 S. japonicum
cercaria. S. japonicum-infected mice were fed 1% taurine in drinking water for 4 weeks
starting at 4 weeks post-infection. Serum levels of alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) were measured by use of a biochemical analyzer.
Data are mean ± SEM of 6e10 mice/group. Con: control group; Inf: infected group;
Tau: infected/taurine-treated group. *p < 0.05, **p < 0.01 vs Con; &: p < 0.05 vs Inf.
Fig. 3. Egg burden is similar in taurine treated and untreated mice infected with S.
japonicum. ICR mice were infected percutaneously with 30 ± 2 S. japonicum cercaria. S.
japonicum-infected mice were fed 1% taurine in drinking water for 4 weeks starting at
4 weeks post-infection. The number of eggs extracted from the liver was determined
by microscopic examination. Data are given as mean ± SEM of 6e8 mice/group. Inf:
infected group; Tau: infected/taurine-treated group. NS: no statistical signiﬁcance.
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granuloma formation
Liver granulomas and ﬁbrosis are the pathological hallmarks of
schistosome infection. To investigate the effect of taurine on
S. japonicum egg-induced liver granuloma, H&E staining of liver
sections was used to analyze the proportion of granulomatous area.
Control livers showed normal cellular organization of uninfected
hepatic lobules, with the typical actinomorphous distribution of
hepatic cords around central veins (Fig. 4A). Infected livers showed
markedly altered histological structure. At 8 weeks post-infection,
inﬂammatory granulomatous lesions were seen in the liver tissue
around schistosome eggs (Fig. 4B). Taurine treatment markedly
reduced the number and diameter of granulomas (Fig. 4C).
Compared with infected mice, taurine-treated mice showed
signiﬁcantly decreased proportion of liver granulomatous area
(Fig. 4D; p < 0.01).
3.5. Taurine treatment reduces S. japonicum egg-induced liver
ﬁbrosis
Liver ﬁbrosis was evaluated by Masson trichrome staining and
IHC staining for a-SMA protein. With Masson trichrome staining,
the collagen ﬁbers were stained blue, cell nuclei were stained black,
and the background was stained red. Control mice showed normal
collagen deposition with periportal few collagen. However, the
amount of collagen ﬁbers was signiﬁcantly increased in infected
liver, with most around granulomas. Compared with infection
alone, taurine treatment decreased collagen deposition (Fig. 5A).
Activation of HSCs into ﬁbroblasts is the key event in the process
of liver ﬁbrosis. Expression of a-SMA is commonly used as a hall-
mark of the activated HSCs. IHC staining for a-SMA revealed
signiﬁcantly increased amount of a-SMAþ cells in liver of infectedFig. 4. Taurine suppresses S. japonicum egg-induced liver granuloma formation. ICR mice we
were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. H&E st
treated mice (original magniﬁcation 50 ). Arrows indicate granulomatous lesions and arrow
was measured by computer-assisted morphometric analysis. Data are mean ± SEM of 6e8mice but reduced with taurine treatment (Fig. 5B), which was
consistent with the degree of ﬁbrosis. Taurine treatment may
reduce S. japonicum egg-induced liver ﬁbrosis.3.6. Taurine treatment decreases tumor necrosis factor a (TNF-a),
TGF-b1, MCP-1a and MIP-1a mRNA levels
To explore the molecular mechanism underlying the anti-
granulomatous and anti-ﬁbrotic effects with taurine supplemen-
tation, we analyzed the mRNA levels of several granulomatous and
ﬁbrogenic mediators in mice livers. Compared with control mice,
infected mice showed increased levels of TNF-a, TGF-b1, MCP-1a
and MIP-1a (Fig. 6, all p < 0.01). However, taurine supplementation
signiﬁcantly decreased the levels of these cytokines/chemokines
(p < 0.05 for TGF-b1 and MCP-1a, p < 0.01 for TNF-a and MIP-1a).
The ameliorative effects of taurine supplementation on
S. japonicum egg-induced hepatic granulomas and ﬁbrosis may
depend in part on the downregulation of these relevant cytokines/
chemokines.3.7. Taurine treatment markedly suppresses GRP78 level
ER stress plays an important role in the development and pro-
gression of liver ﬁbrosis. Taurine is a well-known ER stress modu-
lator that prevents abnormal protein aggregation and unfolded
protein response. We examined the expression of the ER stress
marker GRP78 in mouse liver by IHC staining and real-time PCR.
GRP78 expressionwas greatly increased in livers of infectedmice as
compared with controls, and taurine supplementation markedly
suppressed GRP78 expression (Fig. 7), which suggests that taurine
attenuating the hepatic pathologic features of infected mice may
involve modulating the ER stress response.re infected percutaneously with 30 ± 2 S. japonicum cercaria. S. japonicum-infected mice
aining of liver sections in (A) control, (B) S. japonicum-infected and (C) infected/taurine-
heads indicate schistosome eggs. (D) The granulomas area as a percentage of total area
mice/group. Inf: infected group; Tau: infected/taurine-treated group. **p < 0.01 vs Inf.
Fig. 5. Taurine reduces S. japonicum egg-induced liver ﬁbrosis. ICR mice were infected percutaneously with 30 ± 2 S. japonicum cercaria. S. japonicum-infected mice were fed 1%
taurine in drinking water for 4 weeks starting at 4 weeks post-infection. Liver tissues were ﬁxed and stained with Masson trichrome or anti-a-smooth muscle actin (SMA) antibody.
(A) Masson trichrome staining for collagen content and distribution. Collagen ﬁbers were stained blue, cell nuclei black, and background red (original magniﬁcation 50 ). (B)
Immunohistochemistry of expression of a-SMA protein in liver tissues (original magniﬁcation 200 ). The quantitative changes were measured by computer-assisted morphometric
analysis. Data are mean ± SEM of 6e8 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. *p < 0.05, **p < 0.01 vs Inf. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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S. japonicum is one of the most common public health problems
in China. Schistosome egg-induced hepatic granuloma formation
can lead to tissue destruction and ﬁbrosis, which causes much of
the morbidity andmortality associated with this disease. Therefore,
inhibiting schistosome egg-induced granuloma and subsequent
ﬁbrosis can prevent the development of the disease. Here, we found
that taurine supplied in drinking water to mice may have signiﬁ-
cant potential as a preventative and therapeutic treatment to
ameliorate hepatic injury and suppress hepatic granuloma forma-
tion and ﬁbrosis during S. japonicum infection.
The formation of schistosome egg-induced hepatic granuloma isa dynamic process triggered by soluble egg antigen secreted from
viable miracidium within eggs trapped in liver tissue. Because of
the continuous antigenic stimulation from the trapped ova, in-
ﬂammatory and immune cells are sequentially recruited to the sites
of infection, thereby leading to the formation of periovular granu-
lomas (Chuah et al., 2014). The liver gradually hardens and is ﬁlled
with many granuloma nodules (Fig. 1A). As well, a severe granu-
lomatous response precipitates ﬁbrosis in the liver quickly and
eventually causes extensive tissue scarring, which in turn causes
severe circulatory impairment of the affected organs. So, granu-
loma formation is the essential pathological lesion of schistoso-
miasis, and blocking its formation is critical for the prognosis of
disease. In the current study, taurine supplied in drinking water to
Fig. 6. Taurine decreases transforming growth factor b1 (TGF-b1), tumor necrosis factor a (TNF-a), monocyte chemotactic protein 1a (MCP-1a) and macrophage inﬂammatory
protein 1a (MIP-1a) mRNA levels. ICR mice were infected percutaneously with 30 ± 2 S. japonicum cercaria. S. japonicum-infected mice were fed 1% taurine in drinking water for 4
weeks starting at 4 weeks post-infection. Real-time quantitative PCR of liver tissue. Data are mean ± SEM of 6e8 mice/group. Con: control group; Inf: infected group; Tau: infected/
taurine-treated group. *p < 0.05, **p < 0.01 vs Con; &: p < 0.05, &&: p < 0.01 vs Inf.
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the gross health state of S. japonicum-infected mice (Figs. 1 and 2).
Although taurine supplementation could not reduce the egg
burden in liver (Fig. 3), it suppressed granuloma formation induced
by S. japonicum eggs (Fig. 4). We conﬁrmed that taurine has hep-
atoprotective effects and can inhibit granuloma formation in
schistosome infection.
During the chronic phase of infection, collagen is increasingly
deposited in the host liver and ﬁbrosis develops. HSCs are one of
the main sources of collagen in the liver and play crucial roles in
schistosome-induced ﬁbrogenesis. Quiescent HSCs primarily func-
tion to store vitamin A, but in response to liver tissue injury, they
are activated and transdifferentiate into myoﬁbroblasts, charac-
terized by the production of ECM components rich in ﬁbrillar col-
lagens (Chuah et al., 2014). Activated HSCs are located at the edges
of hepatic granulomas in mice infected with S. japonicum, as shown
by IHC staining for the HSC marker a-SMA. Because of increased
collagen deposition and portal hypertension, liver function is
further damaged, which leads to liver cirrhosis. Fibrosis is revers-
ible, but cirrhosis is irreversible, so ﬁbrosis progressing to cirrhosis
must be prevented. Previous studies have demonstrated that
taurine can inhibit the deposition of the ECM in the damaged liver
and the proliferation of HSC (Chen et al., 2004). Oral taurine
administration enhances hepatic taurine accumulation, reduces
oxidative stress and prevents the progression of hepatic ﬁbrosis in
rats with carbon tetracholoride-induced hepatic damage andinhibits the transformation of HSCs (Miyazaki et al., 2005). In
addition, natural taurine can promote HSC apoptosis to inhibit
hepatic ﬁbrosis (Deng et al., 2010). Consistent with these results,
our studies showed that taurine supplementation could ameliorate
S. japonicum-induced hepatic ﬁbrosis (Fig. 5).
The initiation, development, and regression of hepatic granu-
loma and ﬁbrosis is mediated by the communication of many cy-
tokines and chemokines. Studies in vitro and in experimental
models in vivo have demonstrated that TNF-a plays a role in
granuloma formation and hepatic ﬁbrosis. In fact, TNF-a seems to
play a central role in promoting periportal ﬁbrosis during Schisto-
soma mansoni infection and was found to be elevated in peripheral
blood eosinophils from chronic S. mansoni-infected patients (De
Souza Rda et al., 2012). TGF-b1 is the most potent ﬁbrogenic cyto-
kine in the liver; its expression is increased during ﬁbrogenesis and
it is the dominant stimulus inducing HSCs to increase ECM syn-
thesis (Dooley and ten Dijke, 2012). Taurine can promote apoptosis
in HSCs by inhibiting the expression of TGF-b1, thereby blocking the
TGF-b1/Smad pathway, a canonical pathway that can potently
regulate hepatic ﬁbrogenesis (Yoshida and Matsuzaki, 2012; Li
et al., 2013). In addition, chemokine MCP-1a can trigger migration
of monocytes into hepatic granulomas. To that effect, the expres-
sion proﬁle of MCP-1a is closely correlated with granuloma diam-
eter and egg burden, so the molecule may play a key role in
initiating and maintaining the immune response to tissue egg
deposition (Bartley et al., 2006). MIP-1a is a marker of disease
Fig. 7. Taurine suppresses the expression of endoplasmic reticulum (ER) stress marker glucose-regulated protein 78 (GRP78). ICR mice were infected percutaneously with 30 ± 2 S.
japonicum cercaria. S. japonicum-infected mice were fed 1% taurine in drinking water for 4 weeks starting at 4 weeks post-infection. (A) Immunohistochemistry of protein
expression of GRP78 in mouse liver tissue (Original magniﬁcation: left, 50 ; right, 200 ). (B) Quantitative PCR analysis of mRNA level of GRP78 in mouse liver tissue. Data are
mean ± SEM of 6e8 mice/group. Con: control group; Inf: infected group; Tau: infected/taurine-treated group. **p < 0.01 vs Con; &: p < 0.05 vs Inf.
Y.-R. Yu et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 35e4342severity in schistosome-infected humans, and experimental studies
in mice suggest that MIP-1a may be a causative factor in the
development of severe schistosomiasis (Souza et al., 2005). We
found that taurine supplementation could downregulate these
granulomatous and ﬁbrogenic mediators in the liver of
S. japonicum-infected mice (Fig. 6), which further conﬁrmed the
anti-granulomatous and anti-ﬁbrotic effects of taurine during
S. japonicum infection.
ER stress plays an important role in the development and pro-
gression of liver ﬁbrosis (Li et al., 2015). The beneﬁcial effects oftaurine are often accompanied by reduced ER stress, which sug-
gests a link between the therapeutic properties of taurine and
restoration of ER homeostasis. Taurine mitigated palmitate-
induced ER stress and cell death in primary hepatocytes and
H4IIE liver cells; part of the protective effects of taurine in diet-
induced nonalcoholic fatty liver disease were related to the
amelioration of ER stress (Gentile et al., 2011). To further determine
the underlying mechanisms of taurine improving the hepatic
pathologic features of S. japonicum-infected mice, we studied the
effect of taurine supplementation on the expression of the ER stress
Y.-R. Yu et al. / International Journal for Parasitology: Drugs and Drug Resistance 6 (2016) 35e43 43marker GRP78 in the liver of infected mice. Taurine supplementa-
tion markedly suppressed GRP78 expression in the liver of infected
mice (Fig. 7), which suggested that taurine attenuating the hepatic
pathologic features of S. japonicum-infected mice may be related in
part to its modulation of the ER stress response. However, the exact
mechanism still needs further investigation.
In conclusion, taurine supplementation could reduce hepatic
lesions and restrain granuloma formation and resultant ﬁbrosis in
S. japonicum-infected mice by downregulating granulomatous and
ﬁbrogenic mediators and alleviating ER stress response. Taurine
may have signiﬁcant potential as a preventative and therapeutic
treatment in S. japonicum infection.
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